Vanguard Group Inc Xencor Inc Transaction History

Vanguard Group Inc

$4.96 Trillion
Q1 2024

A detailed history of Vanguard Group Inc transactions in Xencor Inc stock. As of the latest transaction made, Vanguard Group Inc holds 7,011,042 shares of XNCR stock, worth $133 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

7,011,042

Previous 6,767,249 3.6%

Holding current value

$133 Million

Previous $144 Million 7.99%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$18.65 - $26.52 $4.55 Million - $6.47 Million	243,793 Added 3.6%	7,011,042 $155 Million
Q4 2023 Feb 14, 2024	BUY	$16.53 - $21.42 $1.92 Million - $2.48 Million	115,886 Added 1.74%	6,767,249 $144 Million
Q3 2023 Nov 14, 2023	SELL	$20.08 - $25.39 $180,679 - $228,459	-8,998 Reduced 0.14%	6,651,363 $134 Million
Q2 2023 Aug 14, 2023	SELL	$24.77 - $29.9 $742,233 - $895,953	-29,965 Reduced 0.45%	6,660,361 $166 Million
Q1 2023 May 15, 2023	BUY	$25.95 - $36.95 $988,513 - $1.41 Million	38,093 Added 0.57%	6,690,326 $187 Million

Q4 2022 Feb 10, 2023	BUY	$24.79 - $30.86 $2.25 Million - $2.8 Million	90,733 Added 1.38%	6,652,233 $173 Million
Q3 2022 Nov 14, 2022	BUY	$24.62 - $32.44 $3.78 Million - $4.98 Million	153,529 Added 2.4%	6,561,500 $170 Million
Q2 2022 Aug 12, 2022	BUY	$19.74 - $29.01 $276,142 - $405,820	13,989 Added 0.22%	6,407,971 $175 Million
Q1 2022 May 13, 2022	BUY	$26.68 - $41.63 $1.85 Million - $2.88 Million	69,206 Added 1.09%	6,393,982 $171 Million
Q4 2021 Feb 14, 2022	SELL	$33.67 - $43.44 $1.34 Million - $1.73 Million	-39,814 Reduced 0.63%	6,324,776 $254 Million
Q3 2021 Nov 12, 2021	BUY	$30.65 - $35.68 $1.17 Million - $1.37 Million	38,272 Added 0.6%	6,364,590 $208 Million
Q2 2021 Aug 13, 2021	BUY	$34.33 - $44.68 $217 Million - $283 Million	6,326,318 New	6,326,318 $218 Million

Others Institutions Holding XNCR

# of Institutions

203

Shares Held

64M

Call Options Held

2.2K

Put Options Held

1.3K

View Full List

About Xencor Inc

Ticker XNCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,698,100
Market Cap $1.13B
Description
Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...

More about XNCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Xencor Inc Transaction History